On 23 Oct 2023, GALLANT-1: GB1211 galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) was reported at the ESMO Congress.

This article will teach you three methods to find the corresponding sequence information by the name of an antibody.

Inhibitors of CD38 are a kind of treatment aimed at the white blood cells within bone marrow, which are responsible for inducing multiple myeloma.

This article summarized the latest R&D progress of Retapamulin, the mechanism of action for Retapamulin, and the drug target R&D trends for Retapamulin.

On 23 Oct 2023, the phase Ib/II clinical trial result of Cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma was reported at the ESMO Congress.

Monte Rosa Therapeutics unveils preclinical findings. The research indicates that MRT-6160, a VAV1-specific molecular glue breaker, may be effective in treating immune-based and inflammatory disorders.

Calcineurin inhibitors, acting as immunosuppressive agents, are employed in the treatment of autoimmune disorders like lupus nephritis, atopic dermatitis, interstitial lung disease, and idiopathic inflammatory myositis, among others.

This article summarized the latest R&D progress of Reteplase, the Mechanism of Action for Reteplase, and the drug target R&D trends for Reteplase.

Sunvozertinib (DZD9008) is a targeted, irreversible EGFR inhibitor selective for EGFR mutations. Initial findings for sunvozertinib in treating naïve EGFR exon20ins NSCLC were presented at the ESMO Congress.

At SITC 2023, ENB Therapeutics showcased preliminary findings from the first phase of its ENBOLDEN-101 trial for platinum-resistant ovarian cancer.

C5 inhibitors can defend against biological attacks and control diseases caused by immune responses.

This article summarized the latest R&D progress of Rimegepant Sulfate, the mechanism of action for Rimegepant Sulfate, and the drug target R&D trends for Rimegepant Sulfate.